Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.

Cancer development is like natural selection, involving mutated cells and environmental factors.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Certain drugs that block specific enzymes can help treat prostate diseases.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Dermoscopy is useful for diagnosing various skin, hair, and nail disorders and can reduce the need for biopsies.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

An 81-year-old man's white hair began to regain its original color while he was treated with lenalidomide, suggesting that graying hair might be reversible.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Orlistat might block the body's ability to absorb thyroid medication.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Green tea may help with skin health and protect against UV damage, but more research is needed to confirm its safety and effectiveness.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.